Medisan(SZ:002900) Shang Hai Zheng Quan Bao·2026-02-11 19:01Core Viewpoint - Harbin Sanlian Pharmaceutical Co., Ltd. has completed the registration capital change and has received a new business license following the cancellation of part of its restricted stock incentive plan [1][4]. Group 1: Company Actions - The company held a board meeting on September 17, 2025, and a temporary shareholders' meeting on November 24, 2025, where it approved the proposal to change its registered capital and amend the Articles of Association [1]. - The company repurchased and canceled 3,000 shares from its 2022 restricted stock incentive plan, leading to a reduction in registered capital by 3,000 yuan [1]. Group 2: Registration Details - The new registered capital of the company is 316,354,550 yuan [1]. - The company is classified as a joint-stock company and is located in Harbin, with its legal representative being Qin Jianfei [1]. Group 3: Business Scope - The company is involved in various sectors including drug production, wholesale and retail, cosmetics production, food production, and medical device manufacturing [1][2]. - It also engages in internet sales of food and health products, as well as providing inspection and testing services [2].